Showing results (681-690 of 737) with videos related to

Sort By:
Pageof 74
Laboratory Animal Research|November 11, 2022
Hematological and biochemical reference intervals of wild-caught and inhouse adult Indian rhesus macaques (Macaca mulatta)Niraj A Shah, Laxit K Bhatt, Rajesh J Patel, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2025
Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetesMukul R Jain, Suresh R Giri, Chitrang J Trivedi, et al.
Antioxidants & Redox Signaling|April 2, 2011
Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologiesChanggong Wu, Andrew M Parrott, Cexiong Fu, et al.
Physical Review Letters|October 31, 2025
Crust Composition and the Shallow Heat Source in KS 1731-260R Jain, E F Brown, H Schatz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2017
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH modelsMukul R Jain, Suresh R Giri, Bibhuti Bhoi, et al.
International Journal of Toxicology|December 18, 2023
A Retrospective Comparison of Electrocardiographic Parameters in Ketamine and Tiletamine-Zolazepam Anesthetized Indian Rhesus Monkeys (Macaca mulatta)Laxit K Bhatt, Chitrang R Shah, Shital D Patel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 14, 2012
Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantationF L Kelly, V E Kennedy, R Jain, et al.
Clinical Pharmacology in Drug Development|September 6, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)Deven V Parmar, Kevinkumar A Kansagra, Taufik Momin, et al.
Canadian Journal of Physiology and Pharmacology|May 10, 2007
Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunctionPurvi S Gandhi, Ramesh K Goyal, Anil R Jain, et al.
Journal of Medicinal Chemistry|November 6, 2007
Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology modelBrijesh Kumar Srivastava, Amit Joharapurkar, Saurin Raval, et al.
Pageof 74